Kuros Biosciences obtained U.S. Patent No. 10,064,892, “Method for producing an osteoinductive calcium phosphate and products thus obtained,” addressing MagnetOs bone graft substitute products.
Kuros’ calcium phosphates feature surface topography that instructs the body’s own stem and osteoprogenitor cells to differentiate into bone forming cells.
The company is building intellectual property protection in Australia, Europe and the U.S.
Kuros Biosciences obtained U.S. Patent No. 10,064,892, “Method for producing an osteoinductive calcium phosphate and products thus obtained,” addressing MagnetOs bone graft substitute products.
Kuros' calcium phosphates feature surface topography that instructs the body’s own stem and osteoprogenitor cells to differentiate into bone forming...
Kuros Biosciences obtained U.S. Patent No. 10,064,892, “Method for producing an osteoinductive calcium phosphate and products thus obtained,” addressing MagnetOs bone graft substitute products.
Kuros’ calcium phosphates feature surface topography that instructs the body’s own stem and osteoprogenitor cells to differentiate into bone forming cells.
The company is building intellectual property protection in Australia, Europe and the U.S.
Copy to clipboard 
